Discovery of a potent, selective and orally active canine COX-2 inhibitor, 2-(3-difluoromethyl-5-phenyl-pyrazol-1-yl)-5-methanesulfonyl-pyridine

MLA

Rhonda M. Crosson, et al. “Discovery of a Potent, Selective and Orally Active Canine COX-2 Inhibitor, 2-(3-Difluoromethyl-5-Phenyl-Pyrazol-1-Yl)-5-Methanesulfonyl-Pyridine.” Bioorganic & Medicinal Chemistry Letters, vol. 14, Jan. 2004, pp. 95–98. EBSCOhost, https://doi.org/10.1016/j.bmcl.2003.10.004.

APA

Rhonda M. Crosson, David A. Koss, Michelle L. Haven, Carolyn Rose Kilroy, Martha L. Minich, Robert J. Rafka, Eric L. Nimz, Morton Barry James, Scott B. Seibel, Lisa A. Lund, Carol F. Petras, Kristin M. Lundy DeMello, Chao Li, Annette M. Silvia, Bryson Rast, Kathleen M. Callaghan, Andrei Shavnya, Michael P. Lynch, Subas M. Sakya, … Glen W. Kirk. (2004). Discovery of a potent, selective and orally active canine COX-2 inhibitor, 2-(3-difluoromethyl-5-phenyl-pyrazol-1-yl)-5-methanesulfonyl-pyridine. Bioorganic & Medicinal Chemistry Letters, 14, 95–98. https://doi.org/10.1016/j.bmcl.2003.10.004

Chicago

Rhonda M. Crosson, David A. Koss, Michelle L. Haven, Carolyn Rose Kilroy, Martha L. Minich, Robert J. Rafka, Eric L. Nimz, et al. 2004. “Discovery of a Potent, Selective and Orally Active Canine COX-2 Inhibitor, 2-(3-Difluoromethyl-5-Phenyl-Pyrazol-1-Yl)-5-Methanesulfonyl-Pyridine.” Bioorganic & Medicinal Chemistry Letters 14 (January): 95–98. doi:10.1016/j.bmcl.2003.10.004.